Updates are available Correction dated 2021-04-27
Click to view Correction: https://doi.org/10.1038/s41584-021-00620-3
-
Authors
Barber, Megan R. W. http://orcid.org/0000-0003-1055-1335
Johnson, Sindhu R. http://orcid.org/0000-0003-0591-2976
Gladman, Dafna D. http://orcid.org/0000-0002-9074-0592
Clarke, Ann E. http://orcid.org/0000-0002-3112-9646
Bruce, Ian N. http://orcid.org/0000-0003-3047-500X
- License Information
-
More Information
Article History
First Online: 15 April 2021
Change Date: 27 April 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41584-021-00620-3
Competing interests
: M.R.W.B has received consulting fees from Janssen and Sanofi Genzyme. S.R.J. has received consulting fees from Boehringer Ingelheim and Ikaria. D.D.G. has received grants from AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Pfizer and UCB, and consulting fees from AbbVie, Amgen, BMS, Eli Lilly, Galapagos, Gilead, Janssen, Novartis, Pfizer and UCB. A.E.C. has received consulting fees from AstraZeneca, Exagen Diagnostics, BristolMyersSquibb and GSK. I.N.B. has received grant support from Genzyme/Sanofi, GSK, Roche and UCB; consulting fees from AstraZeneca, Eli Lilly, GSK, Merck Serono, UCB and ILTOO; and was a speaker for AstraZeneca, GSK and UCB.
